---
layout: post
title: "诺瓦瓦克斯医药(NVAX.US)涨2.4% 新西兰批准其新冠疫苗"
date: 2022-02-04 23:33:49 +0800
categories: gelonghui
tags: 格隆汇新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/105.NVAX" data-code="NVAX|105|7" data-code2="NVAX|105|1|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=105.NVAX&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 NVAX_0" data-code="K NVAX|105|7" data-code2="K NVAX|105|1|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>格隆汇2月4日丨诺瓦瓦克斯医药(NVAX.US)涨2.4%；新西兰药品和医疗器械安全局发布了一份临时授权，允许18岁及以上的个人接种诺瓦瓦克斯医药的疫苗。<br /></p><p class="em_media">（文章来源：格隆汇）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202202042267346717>

[返回格隆汇新闻](//finews.withounder.com/category/gelonghui.html)｜[返回首页](//finews.withounder.com/)